Tonix Pharmaceuticals Enters into Exclusive Worldwide Licensing Agreement with OyaGen to Develop Antiviral SARS-CoV-2 Inhibitor, TNX-3500, for the Treatment of COVID-19 - GlobeNewswire
Disease X Will Kill 80 Million In 36 Hours, WHO Panel Warns International Business Times A report by an independent monitoring body assembled by the World Health Organization (WHO) and The World Bank warned that a new pandemic could wipe ...
Comments
Post a Comment